BioTuesdays

Tag - MNKD

BTIG ups MannKind PT to $8 from $4

BTIG raised its price target for MannKind (NASDAQ:MNKD) to $8 from $4, citing a recent meeting with MannKind CEO, Michael Castagna, to hear an extensive discussion on Technosphere and Tyvaso DPI expansion, among other...